Chronic Actinic Dermatitis is a skin condition that is caused by exposure to sunlight. The word "chronic" means ongoing or persistent, while "actinic" refers to the ultraviolet (UV) radiation that causes the condition. "Dermatitis" is a term used to describe an inflammatory skin condition. The pronunciation of this word is ˈkrɑːnɪk ækˈtɪnɪk dɜːrməˈtaɪtɪs. The IPA phonetic transcription shows that the word is pronounced with a long "a" sound in "chronic" and "actinic," while the "er" sound in "dermatitis" is pronounced with a long "ɜː" sound.
Chronic actinic dermatitis is a skin condition characterized by a delayed hypersensitivity reaction to ultraviolet (UV) radiation, predominantly affecting individuals with fair skin and multiple lifetime sun exposures. It is an inflammatory disorder that typically presents as persistent eczema-like rashes in sun-exposed areas such as the face, neck, hands, and forearms.
This condition is considered chronic because it exhibits a recurring and prolonged course, often persisting for years. Actinic dermatitis is primarily caused by an abnormal immune response to UV radiation, which triggers an immune reaction in the skin cells. Over time, this chronic inflammation leads to skin thickening, scaling, and redness.
Common symptoms of this condition include itching, burning, and the formation of papules, vesicles, and plaques on the affected areas. Chronic actinic dermatitis has been associated with significant morbidity, negatively impacting a person's quality of life.
The diagnosis of chronic actinic dermatitis is based on clinical examination, patient history, and the exclusion of other similar dermatological conditions. Dermatologists may perform patch tests or photopatch tests to determine the precise UV radiation triggers for each individual case.
Treatment for chronic actinic dermatitis focuses on minimizing exposure to UV radiation through sun avoidance and protective clothing. Topical corticosteroids and immunomodulatory agents like calcineurin inhibitors are often prescribed to alleviate symptoms and reduce inflammation. In severe cases, systemic therapies such as oral corticosteroids, immunosuppressive drugs, or phototherapy may be necessary.
Long-term management involves vigilant sun protection and regular skin examinations to monitor for any potential skin cancer development, as these individuals are considered at higher risk.